HUP0000679A3 - Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders - Google Patents

Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders

Info

Publication number
HUP0000679A3
HUP0000679A3 HU0000679A HUP0000679A HUP0000679A3 HU P0000679 A3 HUP0000679 A3 HU P0000679A3 HU 0000679 A HU0000679 A HU 0000679A HU P0000679 A HUP0000679 A HU P0000679A HU P0000679 A3 HUP0000679 A3 HU P0000679A3
Authority
HU
Hungary
Prior art keywords
benzazepines
tetrahydro
manufacture
treatment
pharmaceutical composition
Prior art date
Application number
HU0000679A
Other languages
Hungarian (hu)
Original Assignee
Addex Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Addex Pharmaceuticals Sa filed Critical Addex Pharmaceuticals Sa
Priority claimed from PCT/DK1998/000088 external-priority patent/WO1998040072A1/en
Publication of HUP0000679A2 publication Critical patent/HUP0000679A2/en
Publication of HUP0000679A3 publication Critical patent/HUP0000679A3/en

Links

HU0000679A 1997-03-24 1998-03-11 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders HUP0000679A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4150997P 1997-03-24 1997-03-24
PCT/DK1998/000088 WO1998040072A1 (en) 1997-03-12 1998-03-11 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders

Publications (2)

Publication Number Publication Date
HUP0000679A2 HUP0000679A2 (en) 2000-09-28
HUP0000679A3 true HUP0000679A3 (en) 2000-10-30

Family

ID=21916894

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000679A HUP0000679A3 (en) 1997-03-24 1998-03-11 Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders

Country Status (1)

Country Link
HU (1) HUP0000679A3 (en)

Also Published As

Publication number Publication date
HUP0000679A2 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
IL174082A0 (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use for the preparation of a pharmaceutical composition
AU4060599A (en) Pharmaceutical composition for treating or preventing sleep disorders
IL121170A0 (en) Compositions for the treatment of dermatological disorders
IL127714A0 (en) Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic depressive bipolar disorders
HUP0100069A3 (en) 4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders
HUP9904525A3 (en) Pharmaceutical compositions for the treatment of neurological disorders comprising s-(-)-n-propargyl-1-amino indan
HK1028033A1 (en) Sulfonamides for treatment of endothelin-mediated disorders.
HUP0103654A2 (en) Use of smilagenin and anzurogenin-d for production of pharmaceutical compositions for the treatment of alzheimer's disease
HK1026141A1 (en) Treatment of sleep apnea.
IL164839A0 (en) Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas
HUP9802807A3 (en) 1,3,8-triazo-spiro[4,5]decan-4-on derivatives, their use, production thereof and medicaments containing the same
EP1126850A4 (en) Treatment of disorders of the outer retina
HU9700060D0 (en) New compound, it's production and it's use as active component of a medicine
HUP0203611A3 (en) 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments
IL134572A0 (en) Substituted 1,2,3,4,5,6-hexahydro-2,6- methano-3-benzazocine-10-oles, methods for the production and use thereof as medicaments
CA2260863A1 (en) Treatment of psychotic disorders
CZ20011872A3 (en) Isonipecotamides for the treatment of integrin-mediated disorders
ZA981918B (en) Use of 2,3,4,5-tetrahydro-1H-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
HUP0000679A3 (en) Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders
EP0755262A4 (en) Composition for the treatment of lung disease
AU3071899A (en) Use of pkc-inhibitors for the manufacture of a medicament for the treatment of asthma
ZA98682B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
ZA986324B (en) Composition for the treatment of immunodeficiency disease

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: ADDEX PHARMA SA, CH

Free format text: FORMER OWNER(S): ADDEX PHARMACEUTICALS, SA., CH; CENES LTD., GB

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished